These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11733529)

  • 1. Signal transduction through the B cell antigen receptor is normal in ataxia-telangiectasia B lymphocytes.
    Speck P; Ikeda M; Ikeda A; Lederman HM; Longnecker R
    J Biol Chem; 2002 Feb; 277(6):4123-7. PubMed ID: 11733529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
    Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
    J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
    Fruehling S; Longnecker R
    Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.
    Ikeda M; Ikeda A; Longnecker R
    J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
    Rovedo M; Longnecker R
    J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction.
    Fruehling S; Lee SK; Herrold R; Frech B; Laux G; Kremmer E; Grässer FA; Longnecker R
    J Virol; 1996 Sep; 70(9):6216-26. PubMed ID: 8709248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
    Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
    Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
    J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LMP2A does not require palmitoylation to localize to buoyant complexes or for function.
    Katzman RB; Longnecker R
    J Virol; 2004 Oct; 78(20):10878-87. PubMed ID: 15452208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed ataxia-telangiectasia cells.
    Khanna KK; Yan J; Watters D; Hobson K; Beamish H; Spring K; Shiloh Y; Gatti RA; Lavin MF
    J Biol Chem; 1997 Apr; 272(14):9489-95. PubMed ID: 9083089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.
    Rancan C; Schirrmann L; Hüls C; Zeidler R; Moosmann A
    PLoS Pathog; 2015 Jun; 11(6):e1004906. PubMed ID: 26067064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.
    Ingham RJ; Raaijmakers J; Lim CS; Mbamalu G; Gish G; Chen F; Matskova L; Ernberg I; Winberg G; Pawson T
    J Biol Chem; 2005 Oct; 280(40):34133-42. PubMed ID: 16087662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice.
    Caldwell RG; Brown RC; Longnecker R
    J Virol; 2000 Feb; 74(3):1101-13. PubMed ID: 10627520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
    Portis T; Cooper L; Dennis P; Longnecker R
    Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.
    Miller CL; Longnecker R; Kieff E
    J Virol; 1993 Jun; 67(6):3087-94. PubMed ID: 7684459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation in Epstein-Barr virus LMP2A reveals a role for phospholipase D in B-Cell antigen receptor trafficking.
    Snyder MD; Pierce SK
    Traffic; 2006 Aug; 7(8):993-1006. PubMed ID: 16882041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of Epstein-Barr virus (EBV) genes BBRF3, BILF1, and BMRF2 in EBV-transformed lymphoblastoid lines from ataxia-telangiectasia patients.
    Becker Y; Tabor E; Asher Y
    Leukemia; 1988 Dec; 2(12 Suppl):178S-191S. PubMed ID: 2848995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
    Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
    Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.